BiotechTube

human lactoferrin peptide 1-11

Phase 1/2Withdrawn
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Staphylococcal Infections

Conditions

Staphylococcal Infections, Bacteremia

Trial Timeline

Feb 1, 2009 → Oct 1, 2009

NCT ID
NCT00509847

About human lactoferrin peptide 1-11

human lactoferrin peptide 1-11 is a phase 1/2 stage product being developed by AM-Pharma for Staphylococcal Infections. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00509847. Target conditions include Staphylococcal Infections, Bacteremia.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (2)

NCT IDPhaseStatus
NCT00509847Phase 1/2Withdrawn
NCT00509938Phase 1/2Completed

Competing Products

20 competing products in Staphylococcal Infections

See all competitors
ProductCompanyStageHype Score
CeftobiproleJohnson & JohnsonPhase 1
33
CeftobiproleJohnson & JohnsonPhase 1
33
Daptomycin + VancomycinMerckApproved
85
Daptomycin 4 mg/kg + Comparator: vancomycin + Daptomycin 6 mg/kgMerckPhase 3
77
V710 + PlaceboMerckPhase 1
33
V710 + Comparator: PlaceboMerckPhase 1
33
V710 (30 µg) with MAA + V710 (30 µg) without MAAMerckPhase 1
33
Daptomycin + VancomycinMerckApproved
85
DaptomycinNovartisApproved
85
SA4Ag vaccinePfizerPhase 1
32
Staphylococcus aureus 4-Antigen (SA4Ag) VaccinePfizerPhase 2
51
linezolid (Zyvox)PfizerPre-clinical
22
Staphylococcus aureus 4-antigen vaccine + PlaceboPfizerPhase 2
51
TigecyclinePfizerApproved
84
SA4Ag vaccine low dose + SA4Ag vaccine mid dose + SA4Ag vaccine high dose + PlaceboPfizerPhase 1
32
SA4Ag vaccine low dose + SA4Ag vaccine mid dose + SA4Ag vaccine high dose + SA3Ag vaccine + PlaceboPfizerPhase 1
32
NDV-3 vaccine with alum IM + NDV-3 vaccine without alum IM + Placebo with alum IM + NDV-3 vaccine without alum IDUnited TherapeuticsPhase 1
30
NDV-3 investigational vaccineUnited TherapeuticsPhase 1
30
TD-1792 + VancomycinTheravance BiopharmaPhase 2
47
CeftobiproleBasilea PharmaceuticaPhase 1
28

Other Products from AM-Pharma

Recombinant human alkaline phosphatasePhase 3
69
Ilofotase alfa + PlaceboPhase 2
44
Alkaline Phosphatase + PlaceboPhase 2
44
recAPPhase 2
44
Placebo + BIAPPhase 2
44